ロード中...
Cell Therapy for Parkinson’s Disease: New Hope from Reprogramming Technologies
Parkinson’s disease (PD) is a neurodegenerative disease with the major pathology being the progressive loss of dopaminergic (DA) midbrain neurons in the substantia nigra. As early as in the 1980s, open-label clinical trials employing fetal ventral mesencephalon (fVM) tissues have demonstrated signif...
保存先:
| 出版年: | Aging Dis |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
JKL International LLC
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4657821/ https://ncbi.nlm.nih.gov/pubmed/26618051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14336/AD.2014.1201 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|